Teva UK Limited Launches Generic Tolterodine in all Strengths and Formulations

Informations

• Publié par: teva-uk-limited
• Nombre de lectures: 11
• Langue: English

Extrait

Teva UK Limited Launches Generic Tolterodine in all Strengths and Formulations

PR Newswire CASTLEFORD, England, September 10, 2012

CASTLEFORD, England,September 10, 2012/PRNewswire/ -- We are pleased to announce the launch of generic Tolterodine 1mg and 2mg film-coated tablets, and Tolterodine XL (Mariosea XL) 4mg capsules. ® Tolterodine is a generic version of Detrusitol(tolterodine) from Pfizer. ® Tolterodine XL (Mariosea XL) is a generic version of DetrusitolXL (tolterodine XL) from Pfizer.Both are indicated in the symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome.Please see the Summaries of Product Characteristics for more in-depth information. Tolterodine and Tolterodine XL (Mariosea XL) are available immediately in the award-winning Teva 360 livery. Kim Innes, Commercial Director at Teva said: "With the launch of tolterodine in all strengths and formulations, we're making more medicines accessible for more people. We've now launched twenty-four new products in 2012, and the launch of tolterodine is our twelfth patent expiry of the year so far. It adds to Teva's portfolio of medicines, which is already the UK's widest." [1] "More than 1.2 million prescriptions are written each year in the UKfor tolterodine or tolterodine XL, and the availability of generic tolterodine will save the NHS millions of pounds each year. It and other patent expiries provide pharmacy the opportunities for increasing margins and keeping costs down, and also mean we at Teva continue to do our bit in saving the NHS over £9bn a year through the availability of generic medicines." New or existing customers can order through their local Teva Territory Sales Manager, through major wholesalers, or call0800-085-8621. To find out more about Teva UK Limited, visit http://www.tevauk.com.

About Teva UK Limited

Teva UK Limited is one of the UK's top ten pharmaceutical manufacturers, with a presence in the generics, branded respiratory and hospitals markets. It has the widest range of any UK generic pharmaceutical company and markets solid and liquid dose, injectable and respiratory medicines to healthcare professionals. The company is part of Teva Pharmaceutical Industries Ltd.

About Teva Pharmaceutical Industries Ltd

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered inIsrael, Teva is the world's largest generic drug maker, with a global product portfolio of more than 1,300 molecules and a

direct presence in about 60 countries. Teva's branded businesses focus on CNS, oncology, pain, respiratory and women's health therapeutic areas as well as biologics. Teva currently employs approximately 46,000 people around the world and reached$18.3 billionin net revenues in 2011.

Notes to Editors:

1. IMSHealth UK Limited, Xponent NPA, Rx written, MATDecember 2011.